Related Experiment Video
Updated: Feb 9, 2026

08:15
Author Spotlight: Unveiling Plankton Response to Climate Change Through Time-Series Data and Artistic Expression
Published on: July 28, 2023
1.9K
Accurately depicting pathological gamblers: Policy and treatment implications
1Policy Research Associates, Inc., USA.
Journal of Gambling Studies
|November 19, 2013
Summary
This 3-year study identified two distinct pathological gambling groups in the general population, differing in income, demographics, and behaviors. Findings challenge existing beliefs and call for broader outreach strategies for gambling disorder.
Area of Science:
- Psychology
- Public Health
- Behavioral Science
Background:
- Pathological gambling is a significant public health concern.
- Previous research often focused on a single profile of pathological gamblers.
- Understanding diverse gambling behaviors in the general population is crucial.
Purpose of the Study:
- To investigate the heterogeneity of pathological gambling within the general population.
- To identify distinct subgroups of pathological gamblers based on key characteristics.
- To challenge and refine existing assumptions about pathological gamblers.
Main Methods:
- Conducted a 3-year study involving the general population.
- Utilized income as a primary differentiator for subgroup analysis.
- Collected data on demographic characteristics, gambling involvement, and problematic behaviors.
Main Results:
- Identified two distinct pathological gambler groups based on income.
- Observed significant variations in demographics, gambling involvement, and behaviors between groups.
- These findings contrast with current understandings of pathological gambling.
Conclusions:
- Pathological gambling presents with diverse profiles, not a monolithic entity.
- Current outreach and treatment models may not encompass all affected individuals.
- Expanded and inclusive strategies are needed for gambling disorder interventions.
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
968
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
Anticholinesterase Agents: Poisoning and Treatment
1.7K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K
Angle Closure Glaucoma: Treatment
1.3K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K

